Could High Drug Prices Be Bad for Innovation?
Industry leaders argue that high prices are necessary for innovation, but just how high do prices need to be?
Originally published on 10/23/2014 in Forbes: Cancer
Policymakers have been scrutinizing high drug prices like never before, and a series of six figure drugs are to blame.
The pharmaceutical industry has responded by stating these high prices are necessary to fuel the fire of innovation. But when does the potential to profit exceed that which is needed to drive innovation and pervert the market? Dr. Bach thinks we're already there.
Read the full article here.